Home > PJ (current issue) > Broad Spectrum | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7354 p758
18 June 2005

This article
Reprint   Photocopy

PDF 45K, Acrobat Reader

Comment

Implications of medication reviews for postgraduate education and training

By Sharon Steel

Sharon Steel, partner and senior pharmaceutical consultant, Pharmaceutical Resource Network

Since publication of the HOMER study about home medication review (PJ, 22 January, p71), much has been written about the implications for medication review by pharmacists but little consideration has been given to the implications for pharmacy postgraduate education and training.

In the HOMER study, pharmacists could participate if they held a postgraduate qualification in pharmacy practice or had recent continuing professional development in therapeutics. All pharmacists participated in a two-day training course, including lectures on adverse drug reactions, prescribing in elderly people, improving concordance and communication skills. However, as a recent correspondent in The Pharmaceutical Journal pointed out with respect to prescribing, “being trained and being competent are not the same thing” (PJ, 28 May, p645).

Over the past eight years, the Pharmaceutical Resource Network (PRN) has delivered high quality, innovative training to pharmacists and prescribers in many primary care organisations to support the implementation of medication review. In PRN’s experience, there are three areas of training provision that are equally important to optimise conditions for delivery of successful patient outcomes from medication review. They are appropriate training content, robust competency assessment and a mechanism for ongoing support during the initial stages of implementing a medication review service.

Training content

The publication of medication review competencies, initially by the National Prescribing Centre and NHS Executive in April 2000 and more recently for the accreditation of pharmacists to provide advanced services in the new community pharmacy contract, has helped to streamline training content and clarify the learning outcomes for training providers.

PRN’s full workshop programme was designed to support practitioners in undertaking full clinical medication review and it fulfils all the competencies specified for accreditation of pharmacists to provide advanced services. Evaluation demonstrates that PRN training gives community pharmacists the confidence to go back to their clinical roots and return to clinical practice.

The training programme is in workshop format to facilitate the development of both clinical and technical knowledge and consulting and decision making skills. The latter are crucial to ensure that participants are able to engage with patients and prescribers. The programme comprises three elements, the first two of which are skills-building and therapeutics-focused workshops. These are presented by a multidisciplinary team of expert teacher-practitioners who can combine theory with experience of hands-on practice in primary care. All materials are updated before every session.

Competency assessment

Crucially, the third element of the programme comprises a competency assessment. This is based on the Objective Structured Clinical Examination (OSCE) originally developed by the University of Dundee as a tool for assessing the competence of trainee doctors. OSCEs are used to test clinical acumen, judgement and practical skills such as consultations.

PRN’s assessment comprises a series of five activities where knowledge and skills are examined according to a previously determined marking scheme. Three activities are written tasks that assess knowledge and two activities comprise assessment of consulting and decision-making skills by real patients and GPs. In our anecdotal experience, the use of patients and GPs in the assessment process is important in determining competency and is likely to give the most accurate assessment of performance in the workplace.

Medicines use review (MUR) and prescription intervention, advanced services in the new NHS community pharmacy contract, require accreditation of both pharmacist and premises. In the MUR model, pharmacists are likely to be doing a review of medicines with the patient but without access to the full clinical record, a scenario similar to that in the HOMER study.

The HOMER study makes no mention of assessing the competency of pharmacists undertaking the medication reviews and it is possible that performance may have influenced the outcomes.

For the purposes of the contract, accreditation of community pharmacists to provide advanced services can only be granted by a higher education institute. At present, to the best of my knowledge, no such accreditation involves face-to-face assessment of pharmacists consulting and decision-making skills or includes any direct patient or GP involvement. This seems far from ideal and may have implications for the effectiveness of advanced services to patients and the NHS.

In order for pharmacists to deliver real benefits from medication review, we surely need robust assessment tools that are proven to demonstrate competence and in which the patient’s experience is central.

Follow-up

Research about training programmes in smoking cessation published recently by NICE identified that pharmacists need more support in translating training into practice (PJ, 11 June, p698). This mirrors PRN’s experience in delivering medication review training and underlines the need for follow-up to training. Since many community pharmacists work in isolation and do not have access to colleagues with more clinical experience, PRN has been commissioned to coach pharmacists delivering new services in primary care. The aim is to use pharmacists who have experience of hands-on practice in primary care to help training participants translate learning into practice. The coaches also give feedback on skills and ongoing problems. We have found that this support is crucial to the success of implementing new medicines management services in the community and boosts confidence and motivation. It is not clear from the HOMER publication if any support was available to the pharmacists conducting the reviews to discuss ongoing problems and options.

Medication review has become a hot topic in health care since the publication of standards in the National Service Framework for Older People. More recently, medication review targets have been included in the new general medical services contract and MUR has become an advanced service in the new pharmacy contract. However, reviews can and are being undertaken by doctors, pharmacists and nurses at a variety of different levels and it is unclear what components produce the best patient outcomes.

Since effective performance of a review, whoever carries it out, is likely to be important, it is in pharmacists’ interests to ensure that postgraduate education and training in this area is indeed fit for purpose. From PRN’s extensive experience of delivering medication review training, all three components of appropriate training content, robust face-to-face competency assessment and a mechanism for ongoing support are required to ensure successful patient outcomes. The profession needs to reflect carefully on the implications of the HOMER study for postgraduate education and training in this area and consider whether the current arrangements will secure effective pharmacist practitioners.

Back to Top


©The Pharmaceutical Journal